FDA — authorised 1 December 2005
- Application: NDA021923
- Marketing authorisation holder: BAYER HLTHCARE
- Local brand name: NEXAVAR
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Sorafenib Tosylate Tablets in United States
FDA authorised Sorafenib Tosylate Tablets on 1 December 2005
Marketing authorisation
Other Oncology approved in United States
Frequently asked questions
Is Sorafenib Tosylate Tablets approved in United States?
Yes. FDA authorised it on 1 December 2005.
Who is the marketing authorisation holder for Sorafenib Tosylate Tablets in United States?
BAYER HLTHCARE holds the US marketing authorisation.